600671 天目药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)5.30628.79734.061-339.450-441.328
总资产报酬率 ROA (%)0.8423.9893.871-11.798-19.148
投入资产回报率 ROIC (%)1.3947.4408.055-28.512-49.337

边际利润分析
销售毛利率 (%)54.75547.76347.38021.78722.934
营业利润率 (%)10.1993.96311.557-30.851-64.168
息税前利润/营业总收入 (%)16.9018.17615.771-23.961-59.650
净利润/营业总收入 (%)6.9613.40210.062-32.268-67.143

收益指标分析
经营活动净收益/利润总额(%)80.19094.27397.72681.95350.760
价值变动净收益/利润总额(%)0.00016.7110.0991.448-1.333
营业外收支净额/利润总额(%)23.71117.91513.618-3.4683.431

偿债能力分析
流动比率 (X)0.8400.8090.7780.8240.561
速动比率 (X)0.7040.6700.5950.6290.346
资产负债率 (%)79.11778.73680.74283.84398.493
带息债务/全部投入资本 (%)53.51046.72944.11732.81442.978
股东权益/带息债务 (%)47.12258.84454.19070.998-31.116
股东权益/负债合计 (%)20.07120.11514.69612.791-4.895
利息保障倍数 (X)4.7862.4426.594-4.092-8.776

营运能力分析
应收账款周转天数 (天)301.609204.353110.37899.756135.909
存货周转天数 (天)181.009148.910149.976171.044214.290